Meng, Fanmao
Ren, Na
Zhang, Guochao
Xu, Ruifeng
Tian, Mengbai
Sun, Xin
Zhao, Liang
Funding for this research was provided by:
the Beijing Natural Science Foundation (7232134)
National Key R&D Program of China (2022YFC2407404)
Beijing Municipal Science & Technology Commission (Z211100002921058)
the Beijing Hope Run Special Fund of Cancer Foundation of China (LC2021A02)
the Chinese Academy of Medical Sciences clinicaland Translational Medicine Research Special Fund (2022-I2M-C&T-B-055)
Capital’s Funds for Health Improvement and Research (2024-2-4027)
Article History
Received: 16 July 2024
Accepted: 4 October 2024
First Online: 22 October 2024
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki, and it was approved by the Clinical Research Ethics Committee of the NCC/CAMS (study approval: 22/243–3445).
: The consent to participate was waived by the Clinical Research Ethics Committee of the NCC/CAMS due to the retrospective nature of this study.
: Not Applicable.
: The authors declare no competing interests.